15
Participants
Start Date
December 16, 2019
Primary Completion Date
December 23, 2022
Study Completion Date
December 23, 2022
Rituximab
Rituximab is given IV weekly x 4 weeks (to be started on study day 7 ± 3 days), then IV q3months x 4 doses (months 4, 7, 10, 13).
Ibrutinib
Ibrutinib is given orally every day (28-day cycles) for a total of 12 cycles.
Northside Hospital, Atlanta
Collaborators (1)
Pharmacyclics LLC.
INDUSTRY
Northside Hospital, Inc.
OTHER